NCT04876963View on ClinicalTrials.gov

HOLT-ED: Holter-monitoring in End-stage Renal Disease

Active, not recruitingOBSERVATIONAL
Enrollment

268

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

September 5, 2024

Study Completion Date

September 5, 2024

Conditions
Kidney Failure, ChronicArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesKidney DiseasesRenal Insufficiency, ChronicRenal Insufficiency
Interventions
DEVICE

Holter-monitor

7-day holtermonitoring of each patient

Trial Locations (3)

2100

Dept. of Nephrology, Rigshospitalet, Copenhagen

Unknown

Herlev Hospital, Herlev

North Zealand Hospital, Hillerød

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER